OTCMKTS:BTCY Biotricity (BTCY) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free BTCY Stock Alerts $1.06 +0.01 (+0.58%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Today's Range$1.03▼$1.0950-Day Range$1.05▼$1.6352-Week Range$0.70▼$4.37Volume16,700 shsAverage Volume80,128 shsMarket Capitalization$9.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… About Biotricity Stock (OTCMKTS:BTCY)Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More BTCY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BTCY Stock News HeadlinesMay 18 at 2:11 AM | americanbankingnews.comBiotricity (OTCMKTS:BTCY) Shares Up 0.6%April 20, 2024 | investing.comBiotricity launches cardiac monitoring pilot with hospital groupMarch 8, 2024 | finance.yahoo.comAre Medical Stocks Lagging HCA Healthcare (HCA) This Year?February 22, 2024 | morningstar.comBiotricity Inc BTCYFebruary 22, 2024 | benzinga.comBiotricity Stock (NASDAQ:BTCY) Earnings Dates and Earning CallsFebruary 19, 2024 | benzinga.comBiotricity's Earnings OutlookFebruary 19, 2024 | finance.yahoo.comBiotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21stFebruary 3, 2024 | msn.comBiotricity Inc. Faces Potential Nasdaq Delisting ThreatJanuary 23, 2024 | finanznachrichten.deBiotricity, Inc.: Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion HeartbeatsJanuary 23, 2024 | finance.yahoo.comBiotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion HeartbeatsNovember 20, 2023 | msn.comHC Wainwright & Co. Downgrades Biotricity (BTCY)November 14, 2023 | msn.comBiotricity reports Q2 resultsNovember 13, 2023 | benzinga.comEarnings Outlook For BiotricityNovember 2, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Releases Another Groundbreaking Product: Biotres ProOctober 31, 2023 | finance.yahoo.comBiotricity Releases Another Groundbreaking Product: Biotres ProOctober 10, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart DeviceOctober 10, 2023 | finance.yahoo.comBiotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart DeviceOctober 4, 2023 | finanznachrichten.deBiotricity, Inc.: CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres DeviceOctober 4, 2023 | finance.yahoo.comCORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres DeviceSeptember 29, 2023 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Could Be Riskier Than It LooksAugust 28, 2023 | usatoday.comWhy Biotricity and Waqaas Al-Siddiq are Revolutionizing Modern HealthcareAugust 20, 2023 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Q1 2024 Earnings Call TranscriptAugust 15, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business UpdatesAugust 15, 2023 | finance.yahoo.comBiotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business UpdatesAugust 14, 2023 | finance.yahoo.comBiotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15thSee More Headlines Company Calendar Last Earnings2/20/2024Today5/19/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:BTCY CUSIPN/A CIK1630113 Webwww.biotricity.com Phone(650) 832-1626FaxN/AEmployees55Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,660,000.00 Net Margins-163.11% Pretax Margin-163.11% Return on EquityN/A Return on Assets-252.90% Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.14 Sales & Book Value Annual Sales$11.63 million Price / Sales0.86 Cash FlowN/A Price / Cash FlowN/A Book Value($2.67) per share Price / Book-0.40Miscellaneous Outstanding Shares9,420,000Free Float6,963,000Market Cap$9.99 million OptionableNot Optionable Beta1.54 Key ExecutivesDr. Waqaas Al-Siddiq Ph.D. (Age 39)Founder, President, CEO & Chairman Comp: $732kMr. S. John Ayanoglou (Age 57)Chief Financial Officer Comp: $305.75kMr. Andy WongVice President of OperationsDr. George N. NikopoulosDirector of Business DevelopmentMr. Matt ZabelVice President of Sales & StrategyMr. Amir AliChief Development OfficerMore ExecutivesKey CompetitorsAinosOTCMKTS:AIMDXylo TechnologiesNASDAQ:MDGSGuardion Health SciencesNASDAQ:GHSIPHAXIAM TherapeuticsNASDAQ:PHXMBioCardiaNASDAQ:BCDAView All Competitors BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed in 2024? Biotricity's stock was trading at $1.15 at the beginning of 2024. Since then, BTCY stock has decreased by 7.8% and is now trading at $1.06. View the best growth stocks for 2024 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (OTCMKTS:BTCY) announced its quarterly earnings results on Tuesday, February, 20th. The company reported ($0.34) earnings per share for the quarter, topping analysts' consensus estimates of ($0.41) by $0.07. The firm had revenue of $2.97 million for the quarter, compared to analyst estimates of $3 million. When did Biotricity's stock split? Biotricity shares reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF). How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BTCY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding Biotricity, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
